These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38986873)

  • 1. Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors.
    Andreev K; Jones JC; Seiler P; Kandeil A; Webby RJ; Govorkova EA
    Antiviral Res; 2024 Sep; 229():105959. PubMed ID: 38986873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018.
    Takashita E; Daniels RS; Fujisaki S; Gregory V; Gubareva LV; Huang W; Hurt AC; Lackenby A; Nguyen HT; Pereyaslov D; Roe M; Samaan M; Subbarao K; Tse H; Wang D; Yen HL; Zhang W; Meijer A
    Antiviral Res; 2020 Mar; 175():104718. PubMed ID: 32004620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022-2023.
    Andreev K; Jones JC; Seiler P; Kandeil A; Turner JCM; Barman S; Rubrum AM; Webby RJ; Govorkova EA
    J Infect Dis; 2024 Jun; 229(6):1830-1835. PubMed ID: 37770028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020.
    Govorkova EA; Takashita E; Daniels RS; Fujisaki S; Presser LD; Patel MC; Huang W; Lackenby A; Nguyen HT; Pereyaslov D; Rattigan A; Brown SK; Samaan M; Subbarao K; Wong S; Wang D; Webby RJ; Yen HL; Zhang W; Meijer A; Gubareva LV
    Antiviral Res; 2022 Apr; 200():105281. PubMed ID: 35292289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022.
    Nguyen HT; Chesnokov A; De La Cruz J; Pascua PNQ; Mishin VP; Jang Y; Jones J; Di H; Ivashchenko AA; Killian ML; Torchetti MK; Lantz K; Wentworth DE; Davis CT; Ivachtchenko AV; Gubareva LV
    Antiviral Res; 2023 Sep; 217():105679. PubMed ID: 37494978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuraminidase inhibitors susceptibility profiles of highly pathogenic influenza A (H5N1) viruses isolated from avian species in India (2006-2015).
    Sood R; Kumar N; Bhatia S; Chanu KV; Gupta CL; Pateriya AK; Mishra A; Khandia R; Mawale N; Singh VP
    Antiviral Res; 2018 Oct; 158():143-146. PubMed ID: 30125616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of PA/I38 substitutions and PA polymorphisms on the susceptibility of zoonotic influenza A viruses to baloxavir.
    Taniguchi K; Noshi T; Omoto S; Sato A; Shishido T; Matsuno K; Okamatsu M; Krauss S; Webby RJ; Sakoda Y; Kida H
    Arch Virol; 2024 Jan; 169(2):29. PubMed ID: 38216710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility.
    McKimm-Breschkin JL; Barrett S; Wong FYK; Pudjiatmoko ; Azhar M; Selleck P; Davies KR; Hartaningsih N; McGrane J
    Antiviral Res; 2018 May; 153():95-100. PubMed ID: 29574145
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Jeong JH; Choi WS; Antigua KJC; Choi YK; Govorkova EA; Webby RJ; Baek YH; Song MS
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.
    Gubareva LV; Besselaar TG; Daniels RS; Fry A; Gregory V; Huang W; Hurt AC; Jorquera PA; Lackenby A; Leang SK; Lo J; Pereyaslov D; Rebelo-de-Andrade H; Siqueira MM; Takashita E; Odagiri T; Wang D; Zhang W; Meijer A
    Antiviral Res; 2017 Oct; 146():12-20. PubMed ID: 28802866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.
    Baek YH; Song MS; Lee EY; Kim YI; Kim EH; Park SJ; Park KJ; Kwon HI; Pascua PN; Lim GJ; Kim S; Yoon SW; Kim MH; Webby RJ; Choi YK
    J Virol; 2015 Jan; 89(1):287-99. PubMed ID: 25320319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
    Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Susceptibilities of Avian Influenza A(H5), A(H7), and A(H9) Viruses Isolated in Japan.
    Takashita E; Morita H; Nagata S; Shirakura M; Fujisaki S; Miura H; Takayama I; Arita T; Suzuki Y; Yamaoka M; Tanikawa T; Tsunekuni R; Mine J; Sakuma S; Uchida Y; Shibata A; Iwanaka M; Kishida N; Nakamura K; Kageyama T; Watanabe S; Hasegawa H;
    Jpn J Infect Dis; 2022 Jul; 75(4):398-402. PubMed ID: 34980710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.
    Takano R; Kiso M; Igarashi M; Le QM; Sekijima M; Ito K; Takada A; Kawaoka Y
    J Infect Dis; 2013 Jan; 207(1):89-97. PubMed ID: 23053629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel I117T substitution in neuraminidase of highly pathogenic avian influenza H5N1 virus conferring reduced susceptibility to oseltamivir and zanamivir.
    Kode SS; Pawar SD; Tare DS; Keng SS; Hurt AC; Mullick J
    Vet Microbiol; 2019 Aug; 235():21-24. PubMed ID: 31282375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fitness of influenza A and B viruses with reduced susceptibility to baloxavir: A mini-review.
    Abed Y; Saim-Mamoun A; Boivin G
    Rev Med Virol; 2021 May; 31(3):e2175. PubMed ID: 32975358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of avian influenza A (H9N2) virus with reduced susceptibility to neuraminidase inhibitors oseltamivir and zanamivir.
    Kode SS; Pawar SD; Cherian SS; Tare DS; Bhoye D; Keng SS; Mullick J
    Virus Res; 2019 May; 265():122-126. PubMed ID: 30910698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An influenza A(H5N8) virus isolated during an outbreak at a poultry farm in Russia in 2017 has an N294S substitution in the neuraminidase and shows reduced susceptibility to oseltamivir.
    Svyatchenko SV; Goncharova NI; Marchenko VY; Kolosova NP; Shvalov AN; Kovrizhkina VL; Durymanov AG; Onkhonova GS; Tregubchak TV; Susloparov IM; Gudymo AS; Ilyicheva TN; Ryzhikov AB
    Antiviral Res; 2021 Jul; 191():105079. PubMed ID: 33933515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I222 Neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian Clade 2.1 highly pathogenic Avian Influenza A(H5N1) viruses.
    McKimm-Breschkin JL; Barrett S; Pudjiatmoko ; Azhar M; Wong FY; Selleck P; Mohr PG; McGrane J; Kim M
    PLoS One; 2013; 8(6):e66105. PubMed ID: 23776615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.